Compugen Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Compugen Ltd.

Compugen Ltd. | Mutual Funds

Mutual Funds that own Compugen Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

ARK Innovation ETF

4,050,665

7.09%

1.12%

09/05/2018

ARK Genomic Revolution Multi Sector ETF

2,003,495

3.51%

11,186

2.54%

09/05/2018

DFA Continental Small Company Series

185,531

0.33%

0.01%

01/31/2018

154,507

0.27%

2.52%

09/05/2018

62,296

0.11%

0.46%

09/06/2018

43,659

0.08%

9,489

0.76%

03/31/2018

43,400

0.08%

17,293

1.69%

05/31/2018

Monega Innovation

38,340

0.07%

0.24%

07/31/2018

34,617

0.06%

-23,072

2.31%

06/28/2018

Fidelity Nasdaq Composite Index

25,643

0.05%

07/31/2018

About Compugen

View Profile

Address	Azrieli Center Holon TA 58858 Israel
Employees	-
Website	http://www.cgen.com
Updated	07/08/2019
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.